Bryce Kerlin to Present Cutting-Edge Plasminogen Research at 2026 GRC
Bryce Kerlin, Professor of Pediatrics – Hematology at The Ohio State University, shared a post on LinkedIn:
”I’m excited to present my lab’s work at the Plasminogen Activation and Extracellular Proteolysis GRC, organized by Ze Zheng and Paul Kim in February 2026.
Hope to see you there:
The upcoming 2026 Plasminogen Activation and Extracellular Proteolysis will be taking place February 8-13, 2026, at the Four Points Sheraton / Holiday Inn Express, Ventura, California, USA.
Registration is now open! The conference program highlights the cutting-edge work being conducted in the field. To review the program and apply, please click here.
The deadline to complete registration for this prestigious event will close on January 18, 2026; however, interested applicants should submit their application earlier for consideration.
The 2026 Plasminogen Activation and Extracellular Proteolysis (GRS) Seminar will take place the weekend prior to the GRC and is a wonderful opportunity for graduate students and postdocs to present their research among their peers.
Please share these links with your colleagues and help us spread the word to those who may be interested in attending.”
Keep up with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis